Endocrine therapy in 2009: consideration of the tumor and the host.
Breast cancer is the most common female malignancy in the Western world. Two thirds of all breast cancers are estrogen receptor (ER) positive, a phenotypic characteristic that is prognostic of disease free survival and predictive of response to endocrine therapy.
Oncology